As of Sep 29
| -0.12 / -3.20%|
The 1 analysts offering 12-month price forecasts for Imprimis Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +175.48% increase from the last price of 3.63.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.